anmelden
SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.10.12 | Sonova buy | Vontobel Research | |
| 04.10.12 | Novartis buy | Nomura | |
| 02.10.12 | Tecan (N) neutral | Sarasin Research | |
| 01.10.12 | Novartis buy | Sarasin Research | |
| 01.10.12 | Novartis reduce | Vontobel Research | |
| 27.09.12 | Sonova neutral | Sarasin Research | |
| 27.09.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 24.09.12 | Novartis reduce | Vontobel Research | |
| 24.09.12 | Novartis buy | Sarasin Research | |
| 14.09.12 | Lonza neutral | J.P. Morgan Cazenove | |
| 13.09.12 | Novartis reduce | Vontobel Research | |
| 12.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 11.09.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 11.09.12 | Novartis underperform | Banc of America Securities-Merrill Lynch | |
| 11.09.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 10.09.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 07.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 05.09.12 | Novartis reduce | Vontobel Research | |
| 04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 03.09.12 | Novartis reduce | Vontobel Research | |
| 03.09.12 | Novartis kaufen | Die Actien-Börse | |
| 31.08.12 | Novartis buy | Deutsche Bank AG | |
| 31.08.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 31.08.12 | Novartis buy | Sarasin Research | |
| 30.08.12 | Novartis reduce | Vontobel Research | |
| 29.08.12 | Novartis neutral | Citigroup Corp. | |
| 28.08.12 | Novartis buy | Deutsche Bank AG | |
| 28.08.12 | Novartis reduce | Vontobel Research | |
| 27.08.12 | Straumann reduce | Commerzbank Corp. & Markets | |
| 27.08.12 | Novartis reduce | Vontobel Research | |
| 24.08.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 22.08.12 | Straumann neutral | UBS AG | |
| 22.08.12 | Straumann neutral | Nomura | |
| 22.08.12 | Straumann underperform | Cheuvreux SA | |
| 22.08.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 22.08.12 | Straumann hold | Vontobel Research | |
| 21.08.12 | Straumann neutral | Sarasin Research | |
| 21.08.12 | COLTENE hold | Vontobel Research | |
| 20.08.12 | Novartis neutral | Goldman Sachs Group Inc. |